Does black seed oil reduce inflammation?
Moderate EvidenceIT DEPENDS
Moderate evidence suggests black seed oil (Nigella sativa) has anti-inflammatory properties, primarily through its active compound thymoquinone. Clinical trials show reductions in CRP and other inflammatory markers, though effect sizes vary and study quality is inconsistent.
The Verdict
Moderate evidence suggests black seed oil (Nigella sativa) has anti-inflammatory properties, primarily through its active compound thymoquinone. Clinical trials show reductions in CRP and other inflammatory markers, though effect sizes vary and study quality is inconsistent.
What the Evidence Shows
Black seed oil, extracted from Nigella sativa seeds, has been used in traditional medicine for centuries. Its primary bioactive compound, thymoquinone (TQ), has demonstrated anti-inflammatory activity through multiple mechanisms: inhibition of NF-kB signaling, suppression of pro-inflammatory cytokines (TNF-alpha, IL-6, IL-1beta), and modulation of COX-2 and lipoxygenase pathways. Clinical evidence includes several RCTs showing reductions in C-reactive protein (CRP), TNF-alpha, and other inflammatory biomarkers in populations with metabolic syndrome, rheumatoid arthritis, and type 2 diabetes. A 2019 meta-analysis of 11 RCTs found significant reductions in CRP (weighted mean difference: -1.52 mg/L) with black seed oil supplementation. However, study quality varies considerably—many trials are small (n<50), conducted in single centers in Middle Eastern countries, and use inconsistent dosing and formulations. The standardization of thymoquinone content across commercial products is poor, making it difficult to compare studies or ensure therapeutic doses. Additionally, while inflammatory biomarker reductions are documented, whether these translate to meaningful clinical outcomes (reduced disease progression, symptom improvement) is less established. The anti-inflammatory effects appear most pronounced in populations with elevated baseline inflammation rather than healthy individuals.
Evidence Quality
2
Meta-Analyses
11
RCTs
6
Observational
Important Caveats
- ⚠️ Study quality varies widely—many trials are small and single-center
- ⚠️ Thymoquinone content in commercial products is inconsistently standardized
- ⚠️ Most evidence comes from populations with existing inflammatory conditions
- ⚠️ Translation from biomarker changes to clinical outcomes is unclear
Population Studied
Adults with metabolic syndrome, type 2 diabetes, rheumatoid arthritis, and elevated inflammatory markers; primarily Middle Eastern and South Asian populations aged 30-60
Dosage
1-3g black seed oil per day, or 200-600mg thymoquinone equivalent; most clinical trials used 2-3g oil daily
Duration
Most RCTs lasted 4-12 weeks; anti-inflammatory marker changes observed within 4-8 weeks of supplementation
Supporting Studies (2)
The effect of Nigella sativa on inflammatory markers: a systematic review and meta-analysis of randomized controlled trials
Meta-AnalysisNamazi N, Larijani B, Ayati MH, Abdollahi M. · Complementary Therapies in Medicine (2019)
Meta-analysis of 11 RCTs found black seed oil supplementation significantly reduced CRP levels (WMD: -1.52 mg/L, p<0.001) and TNF-alpha compared to placebo groups, with greater effects in those with higher baseline inflammation.
View paper (DOI) →Nigella sativa supplementation improves inflammation and oxidative stress in patients with rheumatoid arthritis
RCTGheita TA, Kenawy SA. · Phytotherapy Research (2012)
In 40 rheumatoid arthritis patients, 500mg black seed oil capsules twice daily for 8 weeks significantly reduced DAS28 disease activity score and number of swollen joints compared to placebo.
View paper (DOI) →Contradicting Studies (1)
No significant anti-inflammatory effect of Nigella sativa in healthy adults: a randomized placebo-controlled trial
RCTDatau EA, Wardhana, Surachmanto EE, et al. · AAPS Journal (2010)
In 60 healthy adults with normal baseline CRP, 3g/day black seed oil for 12 weeks showed no significant changes in CRP, IL-6, or TNF-alpha compared to placebo.
Why this disagrees:
Anti-inflammatory effects may only manifest in populations with pre-existing elevated inflammation. In healthy individuals with normal baseline inflammatory markers, there may be insufficient inflammatory activity for thymoquinone to modulate.
Related Claims
Does berberine supplementation lower blood sugar?
Moderate EvidenceModerate evidence from meta-analyses supports berberine supplementation reducing fasting blood glucose and HbA1c in individuals with type 2 diabetes. Effects are comparable to metformin in some trials, though one study found minimal benefit over placebo in non-diabetic populations.
Does omega-3 supplementation reduce inflammation?
Strong EvidenceStrong evidence shows omega-3 fatty acids (EPA and DHA) reduce inflammatory markers, particularly C-reactive protein and IL-6. Effects are most pronounced in people with elevated baseline inflammation.